ZLG-13258-74419
4 vaccinations
12 coded responses
53 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 806 / CO
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-24
Survey response — day 0, dose 1MedDRA: Dizziness, Hypoaesthesia — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Light-headedness plus slight facial numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Nasal congestion — Feeling: FairFree text: Stuffy nose and coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-30
-
2021-03-31
Survey response — day 7, dose 1MedDRA: Nasal congestion — Feeling: Fair · HeadacheFree text: Stuffy nose, just allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — day 14, dose 1MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sore throat, stuffy nose, cough - but could just be worsening of allergies.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Numbness in my whole body for several hours overnight, numbness continued in face and neck all dayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-17
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-21
- 2021-05-26
-
2021-07-16
Survey response — 3 months, dose 2MedDRA: Cough, Fatigue, Pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: body aches and fatigue, slight cough and congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-13
-
2021-11-02
Dose 3 — Pfizer-BioNTech
-
2021-11-02
Survey response — day 0, dose 3MedDRA: Dizziness, Hypoaesthesia — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Light-headedness; numbness in face, arms, and handsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Hypoaesthesia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Slight numbness in face and armsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-11-06
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-25
- 2021-11-30
- 2021-12-09
- 2021-12-14
-
2022-02-01
Survey response — 3 months, dose 3MedDRA: Dizziness, Hypoaesthesia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Dizziness and lightheadedness, numbness in feetMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-03
- 2022-05-04
- 2022-11-03
-
2023-01-08
Dose 4 — Pfizer-BioNTech
-
2023-01-08
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2023-01-09
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2023-01-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2023-01-11
- 2023-01-12
- 2023-01-13
-
2023-01-14
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2023-01-15
Health check-in — day 7, dose 4Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2023-01-22
- 2023-01-29
-
2023-02-07
Survey response — day 28, dose 4MedDRA: Abdominal pain lower — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-02-15
Survey response — day 35, dose 4MedDRA: Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-02-19
Survey response — day 42, dose 4MedDRA: Cough, Oropharyngeal pain, Pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-19
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2023-01-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-01 | Successful 2023-02-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-02-19 | Successful 2023-02-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Light-headedness plus slight facial numbness
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Stuffy nose and cough
Release 6 — day 7, dose 1
Systemic reaction (other): Stuffy nose, just allergies.
Release 7 — day 14, dose 1
Symptoms: Sore throat, stuffy nose, cough - but could just be worsening of allergies.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Numbness in my whole body for several hours overnight, numbness continued in face and neck all day
Release 9 — 3 months, dose 2
Symptoms: body aches and fatigue, slight cough and congestion
Release 10 — day 0, dose 3
Systemic reaction (other): Light-headedness; numbness in face, arms, and hands
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Slight numbness in face and arms
Release 11 — 3 months, dose 3
Symptoms: Dizziness and lightheadedness, numbness in feet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain lower | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release